Potential conflict of interest: no conflicts of interest
Clonazepam is an effective treatment for hyperekplexia due to a SLC6A5 (GlyT2) mutation†
Article first published online: 26 JUN 2009
Copyright © 2009 Movement Disorder Society
Volume 24, Issue 12, pages 1852–1854, 15 September 2009
How to Cite
Bakker, M. J., Peeters, E. A.J. and Tijssen, M. A.J. (2009), Clonazepam is an effective treatment for hyperekplexia due to a SLC6A5 (GlyT2) mutation. Mov. Disord., 24: 1852–1854. doi: 10.1002/mds.22493
- Issue published online: 11 SEP 2009
- Article first published online: 26 JUN 2009
- Academical Medical Centre (Bakker & Tijssen)
- Juliana Children's Hospital (Peeters)
Additional Supporting Information may be found in the online version of this article.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.